N-(2-aminoethyl)-N-methylmethanesulfonamide hydrochloride, 95.0%, 10g

4-Iodo-3-(trifluoromethoxy)benzoic acid, 95.0%, 500mg

4-Pyridin-4-yl-butyric acid, 97.0%, 1g

Reaction vials ROTILABO®, 1.5 ml, colourless, Sterile, 500 Piece(s)

1-[4-(DIPHENYLMETHYL)-1-PIPERAZINYL]-3,3-DIPHENYL-1-PROPANONE, 95%, 5mg

3-Iodo-4'-methylbenzophenone, 97.0%, 1g

4-(Trifluoromethoxy)benzenesulfonamide, 95.0%, 25g

7-Methoxy-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-c]pyridine, 95%, 1g

7-Methoxy-8-methyl-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 100mg

3-Chloro-N-phenylpropionamide, 95.0%, 5g

3,3',5,5'-Tetra-tert-butyl-[1,1'-biphenyl]-4,4'-diol, 98%, 100mg

Isobutyric acid, >=99%, for synthesis, 250 ml, glass packaging

N-[(1R*,4R*)-4-Aminocyclohexyl]cyclohexane-carboxamide hydrochloride, 1g